Nascent transcriptome changes in response to CDK12/13 inhibition in gliomas
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
To assess changes in the nascent and steady state transcriptomes after treatment with the CDK12/13 inhibitor THZ531, we performed SLAM-seq in the G7 glioblastoma derived cell line after DMSO treatment or treatment with 500 nM THZ531 for 6 hrs. Overall design: G7 glioblastoma cells were treated with 500 nM THZ531 for 6 hrs or DMSO for 6 hrs.
创建时间：
2026-01-29
